Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that investor meeting that the Company would be participating is scheduled on 31 March 2025 with ‘ICICI Securities’ on a One on One Meeting basis. The Company will be referring to publicly available information for discussions during interaction in the meeting. No confidential / unpublished price sensitive information (UPSI) will be shared during the meeting. The above information shall be made available on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.
